WHO ICTRP trial
Clinical Investigation of Hydromorphone and Sufentanil in Postoperative…
ChiCTR2500096123 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500096123 |
|---|---|
| Public title | Clinical Investigation of Hydromorphone and Sufentanil in Postoperative Patient-Controlled Intravenous Analgesia (PCIA) Following Orthopedic Surgery |
| Scientific title | Clinical Investigation of Hydromorphone and Sufentanil in Postoperative Patient-Controlled Intravenous Analgesia (PCIA) Following Orthopedic Surgery |
| Primary sponsor | Huzhou Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Postoperative analgesia in orthopedics |
| Interventions | Sufentanil group :Sufentanil 100 µg + Palonosetron 0.5 mg + 0.9% normal saline to 100 ml;Hydromorphone group :Hydromorphone 8 mg + Palonosetron 0.5 mg + 0.9% normal saline to 100 ml |
| Registration date | Jan 17, 2025 |
| Target size | Sufentanil group :42;Hydromorphone group :42 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: